Table 3.

Hepatitis C virus (HCV) RNA clearance rates

	HCV RNA clearance rates by PCR
	Intention to treat analysis (n = 171)			Response among those who completed 24 weeks of therapy (n = 136)
	Amantadine	Placebo	p Value	Amantadine	Placebo	p Value
24 wks during treatment	40.0% (n = 34)	45.3% (n = 39)	0.3	49.3% (n = 34)	56.5% (n = 39)	0.2
ETR at 48 wks	32.9% (n = 28)	38.4% (n = 33)	0.3	40.6% (n = 28)	47.8% (n = 33)	0.2
SVR at 24 wks post-treatment	24.7% (n = 21)	27.9% (n = 24)	0.4	30.4% (n = 21)	34.8% (n = 24)	0.4

PCR, polymerase chain reaction; SVR, sustained viral response; ETR, end of treatment response.